9,10-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)anthracene>98.0%(GC)5g

7-Methylenebicyclo[3.3.1]nonan-3-one, 95.0%, 100mg

1-Bromo-2-ethoxy-5-fluorobenzene, 97.0%, 5g

tert-Butyl 4-bromo-2,5-dimethoxybenzylcarbamate, 10g

2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 5g

2,3-Dimethyl-2,3-butanediamine dihydrochloride, 98.0%, 250mg

2,5-DIBROMOBENZYL AMINE HYDROCHLORIDE, 95.0%, 5g

2-[(2-methylphenyl)methyl]butanedioic acid, 95%, 250mg

5-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione, 97%, 10g

Éster bencílico del ácido acético, mínimo 99 %, para síntesis, 2,5 l, envase de vidrio

2,6-Dibromo-4-methylsulfonylaniline, 95.0%, 5g

2-(Pyridin-4-ylmethoxy)phenylboronic acid, 95+%, 1g

5-Cyclopropyl-4-methyl-4H-[1,2,4]triazole-3-thiol, 95.0%, 5g